Bekaert - Update on the Share Buyback Program and Liquidity Agreement Update on the Share Buyback Program and the Liquidity Agreement Period from 19 February 2026 to 25 February 2026 Share Buyback ProgramBekaert announced yesterday that it has completed the fifth tranche of its € 200 million share buyback program. During the tranche, which started 21 November 2025 and ended on 25 February 2026, the company repurchased 620 672 ordinary shares for an aggregate consideration of € 24.5 million. Bekaert announces today that during the period from 19 February 2026 to 25 February 2026, Kepler C...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst Periode van 19 februari 2026 tot 25 februari 2026 Inkoopprogramma van Eigen AandelenGisteren kondigde Bekaert aan dat het de vijfde tranche heeft voltooid van het inkoopprogramma van eigen aandelen van € 200 miljoen. Tijdens deze tranche, die begon op 21 november 2025 en eindigde op 25 februari 2026, heeft het bedrijf 620 672 aandelen teruggekocht voor een totaalbedrag van € 24,5 miljoen. Bekaert kondigt vandaag aan da...
Aalberts: In-line FY25, but low quality / AMG: 4Q25 beat by 7%; in-line 2026 guidance / Bekaert: In-line 2025, cautious outlook for 2026 to result in c.8% consensus cut / CMB.TECH: A small bit beat but not the full story / Corbion: Dividend sweetener / CTP: Q4 results lighter due to some delays; stronger 2026 outlook / DEME: Strong FY25 numbers and FY26 outlook / Elia Group: Preview FY25 results / SBM Offshore: Another step-up in shareholder return / Syensqo: Substantial miss in 4Q25; FY26 outlo...
FY25 uEBIT was in line with earlier guidance and our and consensus forecasts. The FY26 guidance of a flat uEBIT margin is more cautious than our (+0.4pp) and consensus (+0.5pp) forecasts. The healthy free cash flow generation and solid balance sheet allow Bekaert to work on both M&A and share buybacks, and the current share buyback pace (c. €100m/y) in combination with the dividend imply a yearly attractive return to shareholders of c. 9%. With valuation still attractive, we maintain our BUY rat...
Bekaert announces the next tranche of its Share Buyback Program Bekaert announces the next tranche of its Share Buyback Program Bekaert announces that it will start the next tranche of its buyback program on 26 February 2026, for a total consideration of up to € 75 million. It is intended that, subject to market conditions, this tranche will be completed prior to the release of the Q3 trading update, scheduled for 27 November 2026. During this period, Bekaert will regularly publish press releases with updates on the progress made, as required by law. This information will also be available...
Bekaert kondigt de volgende tranche aan van het inkoopprogramma van eigen aandelen Bekaert kondigt de volgende tranche aan van het inkoopprogramma van eigen aandelen Bekaert kondigt aan dat het op 26 februari 2026 zal beginnen met de volgende tranche van het inkoopprogramma van eigen aandelen, voor een totaalbedrag van maximaal € 75 miljoen. Het is de bedoeling dat, afhankelijk van de marktomstandigheden, deze tranche zal worden voltooid voor de publicatie van de Q3 activiteitenverslag op 27 november 2026. Tijdens deze periode, zal Bekaert regelmatig persberichten publiceren met updates ...
Bekaert: 2025 Full Year Results 2025 Full year results Resilient results and strong cash flow supported by cost management and restructuring FCF1 of €314m n Proposed dividend of €1.95 n Ongoing €200m share buyback Bekaert delivered a resilient performance in 2025. The year was marked by shifts in global trade policies which created uncertainty and undermined demand. In addition, slower growth in the hydrogen end market required adjustment to bring footprint in line with demand outlook. At the same time, Bekaert has translated robust demand from investments in power and data transmission ...
Bekaert: Jaarresultaten 2025 Jaarresultaten 2025 Veerkrachtige resultaten en sterke kasstroom ondersteund door kostenbeheer en herstructurering FCF1 van €314m n Voorgesteld dividend van €1,95 n Lopend aandeleninkoopprogramma ter waarde van €200m Bekaert leverde een veerkrachtige prestatie in 2025. Het jaar werd gekenmerkt door verschuivingen in het wereldwijd handelsbeleid die voor onzekerheid zorgden en de vraag ondermijnden. Daarnaast moest de productievoetafdruk worden aangepast aan de vraagvooruitzichten vanwege de tragere groei van de eindmarkt voor waterstof. Tegelijkertijd heeft B...
dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces that following the completion of its €1.08 billion share buyback program in 2025, the company has cancelled 12,049,441 shares. As a result, the total number of issued shares has been reduced by approximately 4.5%, from 265,676,388 to 253,62...
CFE: Preview: underlying 2026 margin to improve / DEME: Preview: strong 2025, eyes on 2026 outlook / JDE Peet's: Acquisition by KDP expected to close in 2Q26 / Solvay: 2025 ends with strong FCF; 2026F und. EBITDA guidance slightly below, supported by one-off / UCB: Peer Moonlake investor day / Vastned: Beat on bottom line with operational metrics accelerating, but outlook remains weak
4Q uEBITDA dropped by c. 30% organ. and was in line with CSS and c. 5% below our forecast. FY26 uEBITDA guidance of € 770-850m represents a 4-13% y/y decline and is at midpoint c. 2% below consensus and 7% below our forecast. The dividend policy (stable to increasing from a € 2.43 base) looks increasingly generous as the FY26 FCF will not be enough to service the dividend and will hence push up leverage from the current 1.8x. Despite the attractive dividend yield (c 9%), the tough market conditi...
Solvay fourth quarter and full year 2025 results Press release Regulated information published on February 24, 2026, at 7:00 a.m. CET Strong free cash flow delivery in 2025 in a challenging environment Highlights Underlying net sales for the full year 2025 were €4.3 billion, -6.5% organically versus 2024. Soda ash seaborne and Coatis markets were weaker in 2025 while Peroxides and bicarbonate grew year-on-year. Underlying EBITDA was €881 million (-13.4% organically versus 2024), maintaining a strong underlying EBITDA margin of 20.7% despite challenges. Strategic t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.